|
CCT6A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.508030E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.739600E-01 |
| Normal-vs-Stage2 |
5.607800E-02 |
| Normal-vs-Stage3 |
7.050400E-01 |
| Normal-vs-Stage4 |
4.406400E-01 |
| Stage1-vs-Stage2 |
2.178200E-01 |
| Stage1-vs-Stage3 |
3.691400E-01 |
| Stage1-vs-Stage4 |
8.837800E-01 |
| Stage2-vs-Stage3 |
9.482000E-02 |
| Stage2-vs-Stage4 |
3.026800E-01 |
| Stage3-vs-Stage4 |
6.364400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.880200E-01 |
| Normal-vs-AfricanAmerican |
7.080100E-02 |
| Normal-vs-Asian |
5.385000E-01 |
| Caucasian-vs-AfricanAmerican |
3.343800E-01 |
| Caucasian-vs-Asian |
7.718000E-01 |
| AfricanAmerican-vs-Asian |
1.916830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.470600E-01 |
| Normal-vs-Female |
1.617180E-01 |
| Male-vs-Female |
9.619200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.484180E-01 |
| Normal-vs-Age(41-60Yrs) |
5.575800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.453010E-01 |
| Normal-vs-Age(81-100Yrs) |
4.007000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.053000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.283600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.290600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.723000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.682400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.965600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.448000E-01 |
| Classical-VS-Follicular |
8.003700E-02 |
| Classical-VS-Other |
3.165600E-01 |
| Classical-VS-Normal |
4.040200E-02 |
| Tall-VS-Follicular |
3.908400E-01 |
| Tall-VS-Other |
4.428400E-01 |
| Tall-VS-Normal |
3.102200E-01 |
| Follicular-VS-Other |
7.330800E-01 |
| Follicular-VS-Normal |
8.440200E-01 |
| Other-VS-Normal |
7.135400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.324600E-01 |
| Normal-vs-N1 |
8.711200E-01 |
| N0-vs-N1 |
5.150400E-01 |
|
|
